Stephanie Favillier
About Stephanie Favillier
Stephanie Favillier is a Disease Area Specialist at Bristol Myers Squibb in Hillingdon, England, with a diverse background in medical affairs, consulting, and healthcare delivery.
Current Position at Bristol Myers Squibb
Stephanie Favillier currently serves as a Disease Area Specialist at Bristol Myers Squibb. Based in Hillingdon, England, she engages in specialized areas of disease management and treatment. Her role includes working on critical disease areas and contributing to medical advancements within the company.
Previous Role at Celgene
From 2021 to 2022, Stephanie Favillier held the position of Senior Manager, Medical Affairs at Celgene. During her tenure, she played a vital role in the medical affairs department, focusing on strategic planning and execution of medical initiatives.
Consultant Experience at Boston Consulting Group
Stephanie Favillier worked as a Consultant at Boston Consulting Group (BCG) from 2019 to 2021. Located in the London, England Metropolitan Area, her responsibilities included providing insightful consulting services to clients, leveraging her medical background to inform business strategies within the healthcare sector.
Educational Background in Medicine
Stephanie Favillier's educational journey in medicine began at The University of Edinburgh, where she studied Reproductive Biology and obtained a Bachelor of Medical Sciences (BMedSci) from 2009 to 2010. She continued her studies at the same institution, earning a Bachelor of Medicine, Bachelor of Surgery (MBChB) from 2007 to 2013.
Clinical Roles in NHS
Stephanie Favillier has an extensive history of clinical roles within the NHS. She served as a Foundation Year 1 Doctor at Imperial College Healthcare NHS Trust from 2013 to 2014, followed by a Foundation Year 2 Doctor position at The Hillingdon Hospitals NHS Foundation Trust from 2014 to 2015. She further specialized in anaesthetics through roles as CT1 at London North West Healthcare NHS Trust (2015-2016) and CT2 at Imperial College Healthcare NHS Trust (2016-2017).